Baird Financial Group, Inc. - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baird Financial Group, Inc. ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$307,268
+13.7%
6,774
+2.8%
0.00%0.0%
Q2 2023$270,347
+11.5%
6,589
-2.9%
0.00%0.0%
Q1 2023$242,424
+92782.8%
6,783
-1.6%
0.00%0.0%
Q4 2022$261
-99.9%
6,893
+1.8%
0.00%0.0%
Q3 2022$300,000
+17.6%
6,772
-1.8%
0.00%0.0%
Q2 2022$255,000
-33.1%
6,897
-33.0%
0.00%0.0%
Q1 2022$381,000
+10.1%
10,293
-9.4%
0.00%0.0%
Q4 2021$346,000
+15.3%
11,356
+26.9%
0.00%0.0%
Q3 2021$300,000
+1.7%
8,949
+21.0%
0.00%0.0%
Q2 2021$295,000
-6.6%
7,396
+5.3%
0.00%0.0%
Q1 2021$316,000
+28.5%
7,027
+68.3%
0.00%0.0%
Q2 2020$246,000
-6.5%
4,175
-24.9%
0.00%0.0%
Q1 2020$263,000
-19.6%
5,559
+2.7%
0.00%0.0%
Q4 2019$327,000
-6.6%
5,414
-7.3%
0.00%0.0%
Q3 2019$350,000
-6.7%
5,841
+0.3%
0.00%0.0%
Q2 2019$375,000
+49.4%
5,824
+88.7%
0.00%0.0%
Q1 2019$251,0003,0870.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,510,173$159,221,4478.52%
Bellevue Group AG 9,233,700$418,840,6326.75%
Deep Track Capital, LP 2,834,069$128,553,3704.96%
BVF INC/IL 4,004,613$181,649,2464.90%
Sicart Associates LLC 203,132$9,214,0683.61%
Camber Capital Management LP 2,250,000$102,0603.36%
Privium Fund Management B.V. 228,493$10,364,4433.08%
Orbimed Advisors 2,169,500$98,408,5202.09%
SECTOR GAMMA AS 165,616$7,512,3421.92%
TANAKA CAPITAL MANAGEMENT INC 14,612$6631.89%
View complete list of IONIS PHARMACEUTICALS INC shareholders